Abstract
Kaj-Åge Henneberg, Tim Tolker-Nielsen, Doaa Higazy, Ulla Rydahl Johansen
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
10.3389/fmicb.2019.00539 · 2019
Effectiveness and safety of colistin among older adults: a systematic review and meta-analysis
10.1093/jac/dkac145 · 2022
Pharmacokinetics/Pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa
10.1128/aac.00126-11 · 2011
Tolerance and resistance of biofilm infections
10.1038/s41579-022-00682-4 · 2022
10.7554/elife.65836.sa2
10.7554/elife.65836.sa2
Genetic and functional diversity of Psseudomonas aeruginosa lipololysaccharide
10.3389/fmicb.2011.00118 · 2011
Rescuing the last-line polymyxins: Achievement and challenges
10.1124/pharmrev.120.000020 · 2021
PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients
10.1128/aac.05391-11 · 2011
PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients
10.1128/aac.05829-11 · 2012
Polymyxin resistance of Pseudomonas phoQ mutants is dependent on additional two-component regulatory systems
10.1128/aac.02353-12 · 2012
The role of the cell envelope in resistance
1975
Adaptive resistance to polymyxin in Pseudomonas aeruginosa due to an outer membrane impermeability mechanism
10.1139/m82-125 · 1982
Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa
10.1046/j.1365-2958.2003.03673.x · 2003
Adaptive resistance to the “last hope” antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-compartment regulatory system ParR-ParS
10.1128/aac.00242-10 · 2010
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
10.1038/35023079 · 2000
The metabolically active subpopulation in Pseudomonas aeruginosa aeruginosa biofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms
10.1111/j.1574-695x.2012.00929.x · 2012
Mechanism and clinical relevance of bacterial heteroresistance
10.1038/s41579-019-0218-1 · 2019
Antibiotic combinations that exploit heteroresistance tdo multiple drugs effectively control infection
10.1038/s41564-019-0480-z · 2019
Formation of Pseudomonas aeruginosa inhibition zone during disk diffusion is due to transition from planktonic to biofilm mode of growth
10.1016/j.ijantimicag.2018.12.015 · 2019
Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumonias, Pseudomonas aeruginosa, and Acinetobacter spp
10.1016/j.cmi.2017.11.020 · 2018
Colistin and polymyxin B susceptibility testing for carbapenem-resistant and mcr-positive Enterobacteriaceae: comparison of sensititre, microscan, vitek 2, and Etest with broth microdilutiuon
10.1128/jcm.00268-17 · 2017
Susceptibility testing for the polymyxins: Two steps back, three steps forward?
10.1128/jcm.00888-17 · 2017
Plastic binding feature of polymyxins: the effect on MIC susceptibility measurements
10.2147/idr.s219130 · 2019
Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia
10.1093/jac/dkq131 · 2010
Polymorphonuclear Leukocytes restrict the Growth of Pseudomonas aeruginosa in Lungs of Cystic Fibrosis Patients
10.1128/iai.01969-14 · 2014
Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratoray infections in patients with cystic fibrosis
10.1128/jcm.33.1.37-40.1995 · 1995
Tolerance to the antimicrobial peptide colistin in P. aeruginosa biofilms is linked to metabolic active cells and depends on the pmr-operon and mexAB-oprM
10.1111/j.1365-2958.2008.06152.x · 2008
Genome organization in Pseudomonas
10.1146/annurev.mi.40.100186.000455 · 1986
Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli
10.1128/jb.62.3.293-300.1951 · 1951
Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum
10.3389/fmicb.2014.00554 · 2014
Inhibition of Pseudomonas aeruginosa quorum sensing by chemical induction of the MexEF-oprN efflux pump
10.1128/aac.01387-23 · 2024
Hackflex: low-cost, highthroughput, illumina nextera flex library construction
2022
Twelve years of SAMtools and BCFtools
10.1093/gigascience/giab008 · 2021
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3
10.4161/fly.19695 · 2012
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin resistance in clinical isolates of Pseudomonas aeruginosa
10.1128/aac.00893-09 · 2009
Calculation of various physics constants in heterogenous substances I. Dielectricity constants and conductivity of mixed bodies from isotropic substances
10.1002/andp.19354160705 · 1935
Hindered diffusion in agarose gels: Test of effective medium model
10.1016/s0006-3495(96)79645-5 · 1996
The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions
10.1038/ncomms13002 · 2016
Antibiotic resistance in P. aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system
10.1128/aac.00428-08 · 2009
Colistin is extensively lost during standard in vitro experimental conditions
10.1128/aac.00857-17 · 2017
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience
10.1016/j.jcf.2008.06.009 · doi-reference
Prevention of chronic colonization with Pseudomonas aeruginosa in patients with Cystic Fibrosis by early treatment with Ciprofloxacin and inhalation with Colistin
10.1016/0140-6736(91)91446-2 · doi-reference
Colistin inhalation therapy in Cystic Fibrosis patients with chronic Pseudomonas aeruginosa lung infection. A prospective double-blind placebo-controlled trial
10.1093/jac/19.6.831 · doi-reference
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients
10.1016/j.jcf.2008.02.003 · doi-reference
Stability of colistin and colistin-methanesulfonat in aqueous media and plasma as determined by high-performance liquid chromatography
10.1128/aac.47.4.1364-1370.2003 · doi-reference
The accessibility of topical treatment in the paranasal sinuses on operated cystic fibrosis patients assessed by scintigraphy
10.4193/rhin17.243 · doi-reference
Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infection
10.1002/ppul.24269 · doi-reference